A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness
- PMID: 27843962
- PMCID: PMC5084483
- DOI: 10.4103/2279-042X.192461
A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness
Abstract
Objective: Drug-drug interactions (DDIs) can cause failure in treatment and adverse events. DDIs screening software is an important tool to aid clinicians in the detection and management of DDIs. However, clinicians should be aware of the advantages and limitations of these programs. We compared the ability of five common DDI programs to detect clinically important DDIs.
Methods: Lexi-Interact, Micromedex Drug Interactions, iFacts, Medscape, and Epocrates were evaluated. The programs' sensitivity, specificity, and positive and negative predictive values were determined to assess their accuracy in detecting DDIs. The accuracy of each program was identified using 360 unknown pair interactions, taken randomly from prescriptions, and forty pairs of clinically important ones. The major reference was a clinical pharmacist alongside the Stockley's Drug Interaction and databases including PubMed, Scopus, and Google Scholar. Comprehensiveness of each program was determined by the number of components in the drug interaction monograph. The aggregate score for accuracy and comprehensiveness was calculated.
Findings: Scoring 250 out of possible 400 points, Lexi-Interact and Epocrates, provided the most accurate software programs. Micromedex, Medscape, and iFacts ranked third, fourth, and fifth, scoring 236, 202, and 191, respectively. In comprehensiveness test, iFacts showed the highest score, 134 out of possible 134 points, whereas Lexi-Interact rated second, with a score of 120. Scoring 370 and 330 out of possible 534 points, Lexi-Interact and Micromedex, respectively, provided the most competent, complete, and user-friendly applications.
Conclusion: Lexi-Interact and Micromedex showed the best performances. An increase in sensitivity is possible by the combination of more than one programs and expert pharmacist intervention.
Keywords: Accuracy; comprehensiveness; drug interaction screening program; drug–drug interactions software.
Similar articles
-
Evaluation of personal digital assistant software for drug interactions.Am J Health Syst Pharm. 2004 Feb 15;61(4):380-5. doi: 10.1093/ajhp/61.4.380. Am J Health Syst Pharm. 2004. PMID: 15011766
-
Evaluation of frequently used drug interaction screening programs.Pharm World Sci. 2008 Aug;30(4):367-74. doi: 10.1007/s11096-008-9191-x. Epub 2008 Apr 16. Pharm World Sci. 2008. PMID: 18415695
-
Performance of drug-drug interaction software for personal digital assistants.Ann Pharmacother. 2006 May;40(5):850-5. doi: 10.1345/aph.1G603. Epub 2006 Apr 18. Ann Pharmacother. 2006. PMID: 16622155
-
Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.Ann Pharmacother. 2008 Dec;42(12):1737-48. doi: 10.1345/aph.1L255. Epub 2008 Nov 25. Ann Pharmacother. 2008. PMID: 19033481 Review.
-
Clinically relevant drug interactions between anticancer drugs and psychotropic agents.Eur J Cancer Care (Engl). 2011 Jan;20(1):6-32. doi: 10.1111/j.1365-2354.2009.01113.x. Eur J Cancer Care (Engl). 2011. PMID: 20030690 Review.
Cited by
-
A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India.Hosp Pharm. 2021 Apr;56(2):109-115. doi: 10.1177/0018578719873876. Epub 2019 Sep 10. Hosp Pharm. 2021. PMID: 33790486 Free PMC article.
-
Prevalence of Drug-Drug Interactions in Older Community-Dwelling Individuals: A Systematic Review and Meta-analysis.Drugs Aging. 2023 Feb;40(2):117-134. doi: 10.1007/s40266-022-01001-5. Epub 2023 Jan 24. Drugs Aging. 2023. PMID: 36692678 Free PMC article.
-
Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa.J Pharm Policy Pract. 2022 Jan 4;15(1):1. doi: 10.1186/s40545-021-00401-z. J Pharm Policy Pract. 2022. PMID: 34983680 Free PMC article.
-
Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study.Int J Clin Pharm. 2022 Apr;44(2):348-356. doi: 10.1007/s11096-021-01346-8. Epub 2021 Nov 23. Int J Clin Pharm. 2022. PMID: 34811600
-
Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.Antibiotics (Basel). 2022 Jul 7;11(7):912. doi: 10.3390/antibiotics11070912. Antibiotics (Basel). 2022. PMID: 35884166 Free PMC article.
References
-
- Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003;21:153–8. - PubMed
-
- Yeh ML, Chang YJ, Wang PY, Li YC, Hsu CY. Physicians' responses to computerized drug-drug interaction alerts for outpatients. Comput Methods Programs Biomed. 2013;111:17–25. - PubMed
-
- Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf. 1993;9:51–9. - PubMed
-
- Glassman PA, Simon B, Belperio P, Lanto A. Improving recognition of drug interactions: Benefits and barriers to using automated drug alerts. Med Care. 2002;40:1161–71. - PubMed
-
- Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health Syst Pharm. 1999;56:1524–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources